FTC sues main pharmacy gain managers around insulin selling prices The agency introduced motion against Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of everyday living-saving insulin medications. Listen to the report 10 min This audio is auto-generated. Be sure https://kethek.com/